IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CLSK

Balance Sheet

(in billions USD)
MetricQ3 2026Q2 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Cash & Equivalents0.200.260.040.030.100.460.120.130.320.050.030.020.010.020.000.000.000.020.020.16
Total Current Assets0.921.101.321.210.951.470.710.600.690.180.100.050.030.050.030.040.020.060.050.18
Total Assets2.702.913.183.102.663.331.961.481.540.860.760.650.530.450.410.420.490.320.300.29
Total Current Liabilities0.160.130.320.280.110.140.190.070.060.040.070.040.040.030.020.020.040.010.010.01
Long-term Debt1.781.790.640.640.641.790.010.000.010.010.010.010.010.01----0.01------
Total Liabilities1.941.931.010.950.771.940.200.070.070.050.080.050.060.050.030.020.060.010.020.01
Retained Earnings(1.15)(0.91)(0.13)(0.12)(0.38)(0.50)(0.48)(0.42)(0.18)(0.30)(0.33)(0.26)(0.24)(0.20)(0.15)(0.12)(0.23)(0.14)(0.13)(0.12)
Total Stockholder Equity0.760.992.182.151.891.381.761.401.460.810.680.600.470.400.380.400.430.310.280.28
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2026Q2 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Interest Expense----5.063.451.271.560.900.490.530.550.600.690.800.700.310.010.890.11----
Net Interest Income----------------------------------0.070.030.03
Pretax Income--(378.34)------(378.71)(62.18)(236.24)126.7425.91(69.39)(14.12)(18.17)(41.15)(16.24)--(30.49)------
Tax Provision2.979.898.7418.113.0431.42(19.14)9.4911.601.400.860.000.000.000.000.000.00------
Net Income(239.84)(378.34)(0.92)257.39(138.79)(378.71)(62.18)(236.24)126.7425.91(74.88)(14.22)(18.46)(42.30)(29.34)(0.17)(29.03)(5.37)(16.68)7.40
Basic EPS------------------------------0.000.35--(0.49)0.28
Diluted EPS------------------------------0.000.35--(0.49)0.22
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ3 2026Q2 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Operating Cash Flow(112.33)(296.96)(119.41)(109.89)(70.60)(161.13)(82.68)(68.04)(42.91)(40.03)(43.94)1.6711.8818.9686.03(33.55)5.12(11.80)(11.94)(4.85)
Capital Expenditures6.1074.52--42.5434.0936.9312.8110.3015.4827.5018.8320.8721.77--3.1928.914.95--4.409.04
Free Cash Flow*(118.43)(371.48)--(152.42)(104.69)(198.06)(95.50)(78.34)(58.39)(67.54)(62.77)(19.19)(9.89)--82.84(62.46)0.16--(16.34)(13.89)
Investing Cash Flow55.4749.00135.50(125.28)(395.47)79.59(416.70)(272.13)(198.75)(32.82)(92.91)(127.95)(111.06)(57.49)(102.82)(50.68)(56.49)(26.62)(135.19)(53.48)
Financing Cash Flow(0.30)465.01(7.65)172.7627.37496.38494.50146.28516.2592.10144.23137.7789.0756.3217.5468.1032.9734.2512.06189.98
← Scroll for more columns →

* Derived from reported values